# MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin

> **NCT00568828** · — · UNKNOWN · sponsor: **The Lowy Medical Research Institute Limited** · enrollment: 12 (estimated)

## Conditions studied

- Macular Teleangiectasia
- Macular Pigment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00568828
- **Lead sponsor:** The Lowy Medical Research Institute Limited
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-12
- **Primary completion:** —
- **Final completion:** 2008-02
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2007-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00568828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00568828, "MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00568828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
